University of Washington
Seattle, WA, United States
MSc in Biomedicine, Lund University Sweden 2007
PhD in Rheumatology, Lund University Sweden 2012
Postdoctoral Associate, Lund University Sweden 2012-2013
Visiting Scientist, University of Washington Seattle, WA, USA 2013-2016
Assistant Professor, University of Washington, Seattle, WA, USA 2016-2022
Associate Professor, University of Washington,
Seattle, WA, USA 2022-
Sunday, November 12, 2023
9:00 AM – 11:00 AM PT
Disclosure(s): Amytryx: Grant/Research Support (Ongoing); Boehringer-Ingelheim: Grant/Research Support (Ongoing); Bristol-Myers Squibb(BMS): Grant/Research Support (Ongoing); Citryll: Consultant (Ongoing); Eli Lilly: Grant/Research Support (Ongoing); Gilead: Grant/Research Support (Ongoing); Horizon Therapeutics: Grant/Research Support (Ongoing); Pfizer: Grant/Research Support (Ongoing); Redd Pharma: Grant/Research Support (Ongoing), Stock options or bond holdings in a for-profit corporation or self-directed pension plan (Ongoing)
Pathogenesis of Calcinosis in Juvenile Dermatomyositis
Monday, November 13, 2023
9:00 AM – 9:15 AM PT
Disclosure(s): Amytryx: Grant/Research Support (Ongoing); Boehringer-Ingelheim: Grant/Research Support (Ongoing); Bristol-Myers Squibb(BMS): Grant/Research Support (Ongoing); Citryll: Consultant (Ongoing); Eli Lilly: Grant/Research Support (Ongoing); Gilead: Grant/Research Support (Ongoing); Horizon Therapeutics: Grant/Research Support (Ongoing); Pfizer: Grant/Research Support (Ongoing); Redd Pharma: Grant/Research Support (Ongoing), Stock options or bond holdings in a for-profit corporation or self-directed pension plan (Ongoing)
13M144: Abstracts: Innate Immunity (1585–1590)
Monday, November 13, 2023
2:00 PM – 3:30 PM PT
Disclosure(s): Amytryx: Grant/Research Support (Ongoing); Boehringer-Ingelheim: Grant/Research Support (Ongoing); Bristol-Myers Squibb(BMS): Grant/Research Support (Ongoing); Citryll: Consultant (Ongoing); Eli Lilly: Grant/Research Support (Ongoing); Gilead: Grant/Research Support (Ongoing); Horizon Therapeutics: Grant/Research Support (Ongoing); Pfizer: Grant/Research Support (Ongoing); Redd Pharma: Grant/Research Support (Ongoing), Stock options or bond holdings in a for-profit corporation or self-directed pension plan (Ongoing)
Monday, November 13, 2023
4:00 PM – 5:30 PM PT
Disclosure(s): Amytryx: Grant/Research Support (Ongoing); Boehringer-Ingelheim: Grant/Research Support (Ongoing); Bristol-Myers Squibb(BMS): Grant/Research Support (Ongoing); Citryll: Consultant (Ongoing); Eli Lilly: Grant/Research Support (Ongoing); Gilead: Grant/Research Support (Ongoing); Horizon Therapeutics: Grant/Research Support (Ongoing); Pfizer: Grant/Research Support (Ongoing); Redd Pharma: Grant/Research Support (Ongoing), Stock options or bond holdings in a for-profit corporation or self-directed pension plan (Ongoing)